Wells Fargo & Company Organogenesis Holdings Inc. Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 41,956 shares of ORGO stock, worth $190,060. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,956

Previous 35,299 18.86%

Holding current value

$190,060

Previous $129,000 47.29%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$3.78 - $5.03 $25,163 - $33,484	6,657 Added 18.86%	41,956 $190,000
Q2 2025 Aug 14, 2025	SELL	$2.66 - $5.34 $13,084 - $26,267	-4,919 Reduced 12.23%	35,299 $129,000
Q1 2025 May 13, 2025	SELL	$2.89 - $6.21 $3,621 - $7,781	-1,253 Reduced 3.02%	40,218 $173,000
Q4 2024 Feb 12, 2025	BUY	$2.77 - $4.43 $26,215 - $41,925	9,464 Added 29.57%	41,471 $132,000
Q3 2024 Nov 13, 2024	BUY	$2.42 - $3.24 $2,867 - $3,839	1,185 Added 3.84%	32,007 $91,000

Q2 2024 Aug 13, 2024	BUY	$2.28 - $3.03 $14,617 - $19,425	6,411 Added 26.26%	30,822 $86,000
Q1 2024 May 10, 2024	BUY	$2.61 - $4.49 $8,198 - $14,103	3,141 Added 14.77%	24,411 $69,000
Q4 2023 Feb 09, 2024	BUY	$1.97 - $4.21 $8,396 - $17,943	4,262 Added 25.06%	21,270 $86,000
Q3 2023 Nov 13, 2023	SELL	$2.34 - $4.43 $23,538 - $44,561	-10,059 Reduced 37.16%	17,008 $54,000
Q2 2023 Aug 15, 2023	BUY	$1.9 - $4.3 $23,666 - $53,560	12,456 Added 85.25%	27,067 $89,000
Q1 2023 May 12, 2023	BUY	$1.89 - $2.93 $20,196 - $31,309	10,686 Added 272.25%	14,611 $31,000
Q4 2022 Feb 13, 2023	SELL	$2.48 - $3.43 $5,446 - $7,532	-2,196 Reduced 35.88%	3,925 $10,000
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $15,181 - $31,089	-4,835 Reduced 44.13%	6,121 $20,000
Q2 2022 Aug 12, 2022	SELL	$4.74 - $8.15 $953,005 - $1.64 Million	-201,056 Reduced 94.83%	10,956 $54,000
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $30,887 - $45,687	4,774 Added 2.3%	212,012 $1.62 Million
Q4 2021 Feb 14, 2022	SELL	$9.02 - $13.5 $2.57 Million - $3.84 Million	-284,775 Reduced 57.88%	207,238 $1.92 Million
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $3.72 Million - $4.67 Million	271,615 Added 123.24%	492,013 $7.01 Million
Q2 2021 Aug 16, 2021	SELL	$14.92 - $23.23 $147,320 - $229,373	-9,874 Reduced 4.29%	220,398 $3.66 Million
Q1 2021 May 13, 2021	BUY	$7.33 - $21.06 $1.22 Million - $3.52 Million	167,072 Added 264.35%	230,272 $4.2 Million
Q4 2020 Feb 09, 2021	BUY	$3.63 - $7.53 $120,624 - $250,221	33,230 Added 110.88%	63,200 $476,000
Q3 2020 Nov 05, 2020	BUY	$3.29 - $4.58 $31,472 - $43,812	9,566 Added 46.88%	29,970 $115,000
Q2 2020 Aug 13, 2020	BUY	$2.86 - $4.61 $28,702 - $46,265	10,036 Added 96.8%	20,404 $78,000
Q1 2020 May 14, 2020	BUY	$2.92 - $5.31 $30,274 - $55,054	10,368 New	10,368 $33,000

Others Institutions Holding ORGO

# of Institutions

127

Shares Held

69.1M

Call Options Held

39.7K

Put Options Held

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $593M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Organogenesis Holdings Inc. Transaction History